Ohcanbohtosat - "disease"

Fáddáevttohusat
Aiddostahte ozu
  1. 1
    Exploring the Neuroprotective Potential of Bovine Colostrum and L-Borneol in Alzheimer's Disease

    Exploring the Neuroprotective Potential of Bovine Colostrum and L-Borneol in Alzheimer's Disease Dahkki Panchal Naitik

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    The Role of Glutathione and Selenium in Management of Alzheimer's Disease

    The Role of Glutathione and Selenium in Management of Alzheimer's Disease Dahkki Mehdi Rizvi

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Exploring the Effect of Lobeglitazone in Neuroinflammatory Pathway of Alzheimer's Disease

    Exploring the Effect of Lobeglitazone in Neuroinflammatory Pathway of Alzheimer's Disease Dahkki More Mrunali

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Design of Metal-Organic Frameworks Of Silibinin in Alzheimer's Disease

    Design of Metal-Organic Frameworks Of Silibinin in Alzheimer's Disease Dahkki Chudiwale Vaishnavi

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Formulation and Optimization of Glutathione (GSH) Niosomes to Improve Oral Bioavailability for Non-Alcoholic Fatty Liver Disease

    Formulation and Optimization of Glutathione (GSH) Niosomes to Improve Oral Bioavailability for Non-Alcoholic Fatty Liver Disease Dahkki Patil Sameer

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Engineering of Iron Oxide Nanoparticles Complexed In-Situ Liposomes For Gastroesophageal Reflux Disease and Iron-Deficiency Anemia

    Engineering of Iron Oxide Nanoparticles Complexed In-Situ Liposomes For Gastroesophageal Reflux Disease and Iron-Deficiency Anemia Dahkki Shah Om

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Potential of Lysozyme and Lysozyme-Silver Complex-based Nanoparticulate Systems in Alzheimer's Disease

    Potential of Lysozyme and Lysozyme-Silver Complex-based Nanoparticulate Systems in Alzheimer's Disease Dahkki Tikale Nayan

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Exploration of Phytochemicals from Ayurvedic Formulations for the Treatment of Parkinson's Disease Using in Silico Approaches

    Exploration of Phytochemicals from Ayurvedic Formulations for the Treatment of Parkinson's Disease Using in Silico Approaches Dahkki Nair Athira

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Development, Characterization, and Pharmacological Evaluation of Baicalin Nanodiamonds for Alzheimer’s Disease.

    Development, Characterization, and Pharmacological Evaluation of Baicalin Nanodiamonds for Alzheimer’s Disease. Dahkki Bajaj Jay

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    "Part I Regulatory Considerations and In-Silico Exploration of Cetilistat in The Treatment Of Non-Alcoholic Fatty Liver Disease Part II Preparation and Documentation of Device Master File"

    "Part I Regulatory Considerations and In-Silico Exploration of Cetilistat in The Treatment Of Non-Alcoholic Fatty Liver Disease Part II Preparation and Documentation of Device Master File" Dahkki Vasekar Amey

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Development of Intranasal Liposomes for Nose to Brain Delivery in Parkinson’s Disease

    Development of Intranasal Liposomes for Nose to Brain Delivery in Parkinson’s Disease Dahkki Shah Pankti

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Design and Synthesis of Quinolone Derivatives as Cholinesterase Inhibitors for Alzheimers Disease

    Design and Synthesis of Quinolone Derivatives as Cholinesterase Inhibitors for Alzheimers Disease Dahkki Itagi Priya

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Identification of Chemical Constituents from Plant Sources Using Poly-Pharmacological Computational Approach for the Treatment of Huntington's Disease

    Identification of Chemical Constituents from Plant Sources Using Poly-Pharmacological Computational Approach for the Treatment of Huntington's Disease Dahkki Kulkarni Laalan

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Identification of Chemical Constituents from Plant Sources Using Poly-Pharmacological Computational Approach for the Treatment of Alzheimer Disease

    Identification of Chemical Constituents from Plant Sources Using Poly-Pharmacological Computational Approach for the Treatment of Alzheimer Disease Dahkki Jadhav Shivani

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    MEDICINE CABINET THE STORY OF HEALTH AND DISEASE TOLD THROUGH EXTRAORDINARY OBJECTS

    MEDICINE CABINET THE STORY OF HEALTH AND DISEASE TOLD THROUGH EXTRAORDINARY OBJECTS Dahkki MCENROE NATASHA

    Almmustuhtton 2019
    Dovdameahttun
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Exploring the Role of NFkB-IDO1 Interplay in the Development of Scopolamine-induced Alzheimer's Disease-like Condition in Rats

    Exploring the Role of NFkB-IDO1 Interplay in the Development of Scopolamine-induced Alzheimer's Disease-like Condition in Rats Dahkki Mr. Dhiraj D. Vispute

    Oahppočájánas Girji
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    ROBBINS & COTRAN PATHOLOGIC BASIS OF DISEASE

    ROBBINS & COTRAN PATHOLOGIC BASIS OF DISEASE Dahkki KUMAR , ABBAS

    Almmustuhtton 2021
    Girji
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    SOME COMMON DISEASES AND THEIR TREATMENT

    SOME COMMON DISEASES AND THEIR TREATMENT Dahkki MALLICK P.N

    Almmustuhtton 2023
    Girji
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    COMMUNICABLE DISEASES

    COMMUNICABLE DISEASES Dahkki MANELKAR R. K

    Almmustuhtton 2012
    Girji
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    COMMUNICABLE DISEASES

    COMMUNICABLE DISEASES Dahkki SAMANT KUSUM

    Almmustuhtton 2006
    Girji
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: